RA Medical Systems (RMED) Financials

$0.38

$-0.01 (-2.70%)

As on 19-Oct-2023 09:30EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.10	0.01	0.02	4.41	7.20	6.26
Cost of Revenue	0.24	0.16	1.56	5.48	8.85	4.21
Gross Profit	-0.13	-0.15	-1.54	-1.08	-1.65	2.05
Operating Expenses	27.70	22.64	27.73	34.98	56.08	33.21
Operating Profit (EBIT)	24.23	-26.96	-29.27	-36.06	-57.73	-31.16
Other Income	--	--	--	0.13	1.04	0.35
Profit before Tax	-87.77	-26.86	-27.26	-36.04	-56.94	-30.82
Provision for Tax	7.83	0.00	0.00	0.01	0.02	0.01
Profit after Tax (Net Income)	-95.59	-26.87	-27.26	-36.05	-56.96	-30.83
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-13.21	--	-25.07	-36.05	-56.96	-30.83

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	35.86	9.26	13.67	21.15	33.15	66.71
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	8.19	0.25	1.98	4.53	4.12	1.38
Current Liabilities	4.45	7.58	5.39	7.76	6.81	5.95
Total Liabilities	52.96	16.84	21.04	33.44	44.08	74.04

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	35.75	0.14	3.96	5.82	8.08	4.80
Current Assets	12.76	16.84	17.09	27.62	36.00	69.23
Total Assets	52.96	16.84	21.04	33.44	44.08	74.04
Total Debt*	0.14	0.12	2.26	4.89	3.50	0.85
Net Current Assets	8.30	9.26	11.70	19.86	29.19	63.28

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-22.57	-27.63	-28.30	-33.17	-18.51
Cash Flow from Investing Activities	--	--	3.80	15.93	-16.03	-0.58
Cash from Financing Activities	--	23.36	14.96	21.69	-0.53	75.17
Net Cash Inflow / Outflow	--	--	--	9.32	-49.73	56.08

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-212.19	-129.91	-115.02	-109.32	-102.77
ROE (%)	-395.23	-234.29	-156.58	-132.77	-114.08	-104.36
ROA (%)	-237.66	-141.84	-100.07	-93.00	-96.44	-72.29
EBIT Margin (%)	23,298.08	-192,578.57	-133,027.27	-818.59	-801.92	-498.00
Net Margin (%)	-91,915.38	-191,892.86	-123,913.64	-794.99	-691.48	-466.52
Cash Profit Margin (%)	-0.05	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-89.84	-0.36	-1.00	-0.39	0.15	0.07
EBIT Growth (%)	184.38	7.88	18.84	37.54	-85.27	-75.45
Net Profit Growth (%)	-309.90	1.45	24.37	36.72	-84.73	-73.55
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.86	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.04	0.86	0.46	0.56	0.48	2.08
Close Price ($)	1.53	5.89	78.00	371.50	1,412.50	9,937.50
High Price ($)	29.50	84.50	491.00	3,359.88	12,737.50	27,500.00
Low Price ($)	1.30	2.03	74.00	212.50	868.75	8,937.50
Market Cap ($ Cr)	3.84	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.01	0.17	0.23	0.11	0.01
Short term debt to equity ratio	0.00	0.00	0.02	0.05	0.02	0.00
Current Ratio	2.86	2.22	3.17	3.56	5.28	11.64
Quick Ratio	2.85	2.22	2.99	3.27	4.88	11.28
Interest Coverage	-775.70	-8.76	-5.08	-333.88	-230.92	-2,225.71

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	76.92	539.90	95.45	5.40	10.92	21.10
Asset Turnover	0.00	0.00	0.00	0.11	0.12	0.15
Receivable days	--	1,259.93	2,149.99	42.45	53.43	53.62
Inventory Days	--	1,177.88	375.08	166.40	100.58	142.98
Payable days	--	1,225.06	182.51	70.06	54.83	67.34
Cash Conversion Cycle	--	1,212.75	2,342.57	138.80	99.17	129.25

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.